Viatris has received a formal rebuke from the US Food and Drug Administration over a direct-to-consumer video that allegedly misled viewers about the use of a cystic fibrosis inhaler. The FDA sent
More
Just over a month before the 250th Independence Day, President Donald Trump issued an Executive Order setting out the federal government’s stance on AI innovation and cybersecurity. The Order directed several agencies
More
Washington state’s decision to cancel its July bar exam has thrown the futures of newly qualified law graduates into serious uncertainty, with consequences felt across the wider legal profession. The cancellation means
More
Senator John Cornyn has fired back at President Donald Trump after Trump threatened to pull Todd Blanche’s Attorney General nomination and resubmit it once two blocking senators leave office. Trump posted on
More
The FTSE 100 recently hit a new all-time high, prompting many investors to reflect on the value of buying into markets during periods of sharp decline. While it may seem counterintuitive, a
More
Warren Buffett, one of the world’s most celebrated investors, has issued a stark warning about the current state of financial markets, describing them as having turned into “gambling.” The Berkshire Hathaway (BRK.A,
More
Recent stock market turbulence has thrown a harsh spotlight on the deeply opaque financial structures underpinning the artificial intelligence industry. The AI sector has grown at a remarkable pace over recent years,
More
Halfords Group, the UK-based cycling and automotive services retailer, is set to rejoin the FTSE 250 index following a period of significant operational improvement. The company’s return to the mid-cap index comes
More
The Financial Conduct Authority believes trading volumes in London are up to three times higher in value than previously recorded once dark trading activity is factored in. Dark trading refers to private
More
Eli Lilly and contract manufacturer Resilience have committed $750 million to significantly expand production of Lilly’s KwikPen injectable device across its diabetes and obesity medicine portfolio. The investment will fund major upgrades
More